Validating A Cardiovascular Risk Tool For Use In A Contemporary Diabetes Population

Published Aug 12, 2013
Cambridge, UK – Originally derived from a group of diabetes patients recruited from the 1970s to the 1990s, the UKPDS outcomes model is a widely-used risk tool for predicting cardiovascular outcomes, such as heart attack and stroke, in patients with diabetes. As treatment of diabetes and its complications has changed considerably since this time, it may no longer be a useful risk prediction tool. Researchers from the MRC Epidemiology Unit at the University of Cambridge used data from a contemporary cohort of individuals with diabetes detected by screening, the ADDITION-Europe study, to test whether the risk score predicted heart attack and stroke over five years. While the model tended to over-estimate risk, it was good at ranking individuals from low to high risk. As such, it is probably still the most appropriate cardiovascular risk prediction tool to use in individuals with diabetes. Dr. Libo Tao, a researcher on the study, says, “It is reassuring that the UKPDS tool can still be used to rank individuals with diabetes from low to high risk in terms of their chance of having a heart attack or stroke. This means the tool can be used to examine the cost-effectiveness of different approaches to treating diabetes from diagnosis.” The full study, “Performance of the UKPDS Outcomes Model for Prediction of Myocardial Infarction and Stroke in the ADDITION-Europe Trial Cohort,” is published in Value in Health.

Value in Health (ISSN 1098-3015) publishes papers, concepts, and ideas that advance the field of pharmacoeconomics and outcomes research as well as policy papers to help health care leaders make evidence-based decisions. The journal is published bi-monthly and has over 8,000 subscribers (clinicians, decision-makers, and researchers worldwide).

International Society for Pharmacoeconomics and Outcomes Research (ISPOR) is a nonprofit, international, educational and scientific organization that strives to increase the efficiency, effectiveness, and fairness of health care resource use to improve health.

For more information: www.ispor.org

Related Stories

Measuring What Matters: Broadening the Scope of Health Economics Evaluation to Incorporate Well-Being

Jul 9, 2024

ISPOR announced the publication of a special themed section of research papers in Value in Health that offer insights into facets of economic evaluation aimed to incorporate well-being into decision making.

Confronting the Backlash Against QALYs: Key Insights From Leading Health Economists

Jun 18, 2024

ISPOR announced the publication of a collection of papers that examine the long-standing debate surrounding the use of quality-adjusted life years (QALYs) and alternative measures in healthcare decision making.

ISPOR Good Practices Report Offers Guidance for Using Real-World Data From EHRs in Health Technology Assessments

Jun 17, 2024

ISPOR announced the publication of an ISPOR Good Practices Report that proposes a framework for assessing the suitability of electronic health records data for use in health technology assessments. The report, “Assessing Real-World Data from Electronic Health Records for Health Technology Assessment: The SUITABILITY Checklist: A Good Practices Report of an ISPOR Task Force” was published in the June 2024 issue of Value in Health.
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×